Skip to main content
Livermore
Livermore
ZHEN

Baker Bros. Advisors LP

SEC CIK
0001263508
Latest filing
Aug 14, 2026

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by Baker Bros. Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overviewAll 13F holders of NRIXFull Q2 2026 holdings

Shares (Q2 2026)
4,658,556
Value
$113.0M
% of portfolio
0.6%
Quarters held
22
Since Q1 2021
Holdings of NRIX by Baker Bros. Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20264,658,556$113.0M0.6%00.0%UnchangedHolders
Q1 20264,658,556$72.2M0.4%00.0%UnchangedHolders
Q4 20254,658,556$88.4M0.5%+776,431+20.0%AddedHolders
Q3 20253,882,125$35.9M0.3%00.0%UnchangedHolders
Q2 20253,882,125$44.2M0.4%00.0%UnchangedHolders
Q1 20253,882,125$46.1M0.5%00.0%UnchangedHolders
Q4 20243,882,125$73.1M0.8%00.0%UnchangedHolders
Q3 20243,882,125$87.2M0.9%00.0%UnchangedHolders
Q2 20243,882,125$81.0M1.0%00.0%UnchangedHolders
Q1 20243,882,125$57.1M0.7%00.0%UnchangedHolders
Q4 20233,882,125$40.1M0.5%00.0%UnchangedHolders
Q3 20233,882,125$30.5M0.2%00.0%UnchangedHolders
Q2 20233,882,125$38.8M0.2%00.0%UnchangedHolders
Q1 20233,882,125$34.5M0.2%00.0%UnchangedHolders
Q4 20223,882,125$42.6M0.3%00.0%UnchangedHolders
Q3 20223,882,125$50.6M0.3%00.0%UnchangedHolders
Q2 20223,882,125$49.2M0.3%+1,428,043+58.2%AddedHolders
Q1 20222,454,082$34.4M0.2%00.0%UnchangedHolders
Q4 20212,454,082$71.0M0.3%00.0%UnchangedHolders
Q3 20212,454,082$73.5M0.3%00.0%UnchangedHolders
Q2 20212,454,082$65.1M0.3%00.0%UnchangedHolders
Q1 20212,454,082$76.3M0.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.